Oura Ring Inc.: Stock (Ticker: OURA) begins trading on Nasdaq by September 30, 2026
Miss
✦ AI-generated prediction
Published on 16. September 2026
·
Predicted for 30. September 2026
·
Based on: Ongoing Event
Oura Ring Inc. — maker of the eponymous health smart ring (sleep, activity, readiness) — filed its S-1 prospectus with the SEC on September 3, 2026. Multiple sources report the company intends to begin trading on Nasdaq as 'OURA' in late September 2026. The IPO environment in the week of September 13–19 saw 13 pricings — the strongest since 2021 — underscoring the open window. Counterbalancing risks: the Fed rate hike to 3.75–4.00% (Sept 16) may briefly dampen valuation appetite; volatility from German state elections (Sept 20) and Russian Duma elections (Sept 20) could force a slip to October. No Polymarket quote found. Estimated ~55% probability for first trading day before September 30, 2026.
Data basis for this prediction
- Oura Ring S-1-Filing beim SEC, 3. September 2026 – Fortune, 16.09.2026
- Geplanter Ticker 'OURA' an der Nasdaq, Erstnotiz 'late September' erwartet – Dhan IPO-Blog / multiple, 16.09.2026
- IPO-Pipeline Woche 13.–19.09.2026: 13 Pricings, stärkstes Quartal seit 2021 – Kiplinger / Dhan, 16.09.2026
- Fed-Zinserhöhung auf 3,75–4,00 % als Bewertungsrisiko – CNBC, 16.09.2026
Note: This is an AI-generated statistical forecast for entertainment and information purposes. It does not constitute investment advice or a recommendation to buy or sell any financial instrument.
Verdict: Miss
Oura Ring Inc. hat den S-1 wie prognostiziert am 3. September 2026 eingereicht und am 21. September 2026 den Roadshow gestartet, mit geplanter Erstnotiz in der Woche ab 28. September 2026 an der Nasdaq (Ticker: OURA, Preisspanne $40–$44, Zielerlös ~2,2 Mrd. $). Am 29. September 2026 – einen Handelstag vor Fristende – wurde das IPO jedoch wegen 'Unsicherheit am IPO-Markt' verschoben. Eine Erstnotiz bis 30. September 2026 fand damit nicht statt. Quellen: Yahoo Finance (https://finance.yahoo.com/markets/stocks/articles/oura-15-6-billion-ipo-182500576.html), Forge Global (https://forgeglobal.com/oura_ipo/), SEC S-1-Filing (https://www.sec.gov/Archives/edgar/data/0002133022/000119312526381855/d119865ds1.htm).
💻 Technology
✦ AI
PLTR closed at $175.40 on November 4, 2026 (after-hours: $170.88, -2.58%; intraday high: $176.54; 52-week high: $212.94). Palantir clearly beat Q3-FY2026 EPS consensus: total revenue $2.313B, US Commercial revenue +148% YoY to $984M. The $185 threshold is +5.5% above the closing price or +8.3% above after-hours levels. Typical post-earnings 'sell the news' may weigh short-term, but the 52-week high of $212.94 confirms the level is reachable. NVIDIA earnings on November 18, 2026 could serve as a sector-wide catalyst. No direct Polymarket equivalent; own estimate: ~42%.
💻 Technology
✦ AI
CBRS trades at $109.18 (October 30, 2026) — already 61% below its all-time high of $279.72. The final and largest lockup expiration is scheduled for November 10, 2026: approximately 19.4 million shares are unlocked (of three tranches of 19.4M each). Prior lockup tranches have consistently weighed on the stock. Insiders have sold ~$394.6M in shares since the May 2026 IPO — zero insider purchases. A Culper Research short-seller report has triggered multiple investigations. A close below $100 requires a ~8.4% decline — plausible given the expected supply pressure on expiration day.
💻 Technology
✦ AI
ARM Holdings reports Q2 FY2027 (July–September 2026) on November 4 after market close. EPS consensus: $0.47; revenue consensus ~$1.38B (Theta Research, Oct 29). ARM is the dominant CPU IP licensor for AI servers (Neoverse), smartphones (Apple A-series, Qualcomm), and edge devices — all three segments scaling strongly in 2026. ARM has beaten EPS consensus in each of the last four quarters, driven by AI infrastructure capex. No direct Polymarket contract; analogue: S&P 500 Q3 2026 beat rate ~71%. Key risks: export control escalation (UK/US vs. China), hyperscaler capex delays, or HBM4 demand plateau.